METHOD OF MODULATION OF INTERACTION BETWEEN RECEPTOR AND LIGAND

Details for Australian Patent Application No. 2003287918 (hide)

Owner ENKAM PHARMACEUTICALS A/S

Inventors Bock, Elisabeth; Berezin, Vladimir; Albrechtsen, Morten

Agent Shelston IP

Pub. Number AU-A-2003287918

PCT Number PCT/DK2003/0009

PCT Pub. Number WO2004/056865

Priority PA 2002 01982 20.12.02 DK; PA 2003 00330 03.03.03 DK

Filing date 18 December 2003

Wipo publication date 14 July 2004

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): PA 2002 01982 20.12.02 DK; PA 2003 00330 03.03.03 DK

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003287918

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287919-Escitalopram hydrobromide and a method for the preparation thereof

2003287917-NOVEL AMINOBENZOPHENONE COMPOUNDS